Advocacy

The National Community Pharmacists Association applauded the Senate for passage of S. 2554, the Patient Right to Know Drug Prices Act, saying the legislation will prohibit "gag clauses" in private health plans.

NACDS praised The Patient Right to Know Drug Prices Act (S. 2554), which is part of the effort to empower pharmacists to help patients lower out-of-pocket drug costs.

The Food and Drug Administration has approved an opioid analgesic risk and evaluation and mitigation strategy as part of a broader set of measures to address the opioid crisis.

The National Association of Chain Drug Stores showed its support for the enactment of an electronic e-prescribing bill that will require healthcare practitioners to have the capability to transmit electronic data transmission prescriptions.

The Senate has passed a package of measures focused on the opioid abuse epidemic, including the Every Prescription Conveyed Securely Act, S. 2460, which is backed by the National Association of Chain Drug Stores.

NACDS is joining forces with Americans for Free Trade in an effort to avert potential harmful consequences of U.S. tariffs and retaliatory actions by trading partners.

NACDS, WSPA, and NCPA praised CMS for rejecting below-cost Medicaid dispensing fees in Washington State, noting that dispensing fees must cover pharamcies’ costs.

In testimony before the House Energy and Commerce Subcommittee on Health, a pharmacist representing NCPA urged support of legislation to prohibit gag clauses that may result in patients being overcharged for medications.